Why Choose Raybow
Raybow pharma has experienced personnel, a long track record and an excellent R&D technology platform for small molecule innovative drugs. We have flexible capacity for production from first batches all the way through to commercialization. As a leading enterprise in the field of global new drug Contract Development and Manufacturing Organizations (CDMOs), Raybow is committed to provide its global partners with “One-Stop Service”. We cover all stages of drug developement, from new drug pre-clinical research to commercial production. High quality, high efficiency, and high flexibility are what we are known for.
Commitment to technical excellence
- We employ more than 300 chemists, 10% of which are PhDs, and greater than 50% have master degrees.
- Syntheses – incorporating environmental considerations
- Experienced in process development and scale up
- Safety evaluation – HAZOP, RC1, ARC, DSC, TGA etc.
Flexible & cost efficient
- Multiple sites (US and China), multiple manufacturing plants
- Flexible production planning
- Excellent Experienced English-speaking project and scientific management
- Dependable and sustainable supply-chain management
Excellence in Quality
- Successfully passed worldwide regulatory authority inspections (US FDA, CFDA, AIFA,ANVISA, Cofepris, PMDA etc.)
Commitment to excellence in HSE
- ISO14000/OHSAS18000 certified system
- Environmental hazard identification, risk assessment and risk control
- In-house waste treatment system